抗胆固醇负担和抑郁症对老年人跌倒风险的协同作用
Raymond Salet1, Nathalie van der Velde2,3, Didi Rhebergen3,4,5
1Department of Psychiatry, University Medical Centre Utrecht, Utrecht, The Netherlands.
British journal of clinical pharmacology
|July 1, 2025
概括
在老年人中,高抗胆固醇负担 (ACB) 和抑郁症独立地增加了跌倒风险. 抑郁症显著放大了ACB和跌倒之间的关联,突出了需要谨慎的药物管理.
科学领域:
- 老年学是一门学科.
- 临床药房 临床药房
- 精神病学是一个精神病学.
背景情况:
- 抗胆固醇负担 (ACB) 和抑郁是老年人跌倒的确立危险因素,有助于增加发病率和死亡率.
- 关于跌倒风险的抑郁症和ACB之间的相互作用仍然不清楚,特别是考虑到一些抗抑郁药具有抗胆性质.
研究的目的:
- 调查抗胆固醇负担与社区老年人的跌倒之间的关系.
- 确定临床抑郁症对抗胆固醇负担和跌倒风险之间的关联的影响.
主要方法:
- 一项横截面研究分析了7884名社区居住的荷兰老年人的数据.
- 评估了抗胆固醇负担,临床抑郁症和过去12个月的跌倒.
- 进行了调整的赔率比率 (OR),95%的置信区间 (CI) 和相互作用分析.
主要成果:
- 高抗胆固醇负担 (ACB评分≥3) 和临床抑郁症都与跌倒风险增加显著相关.
- 在ACB和临床抑郁症之间观察到对跌倒风险的统计学显著相互作用 (P=0.038),其乘法和加法效应分别为1.44和1.13.
结论:
- 临床抑郁症加剧了与老年人抗胆固醇负担相关的跌倒风险增加.
- 虽然不鼓励拒绝必要的抗抑郁药治疗,但建议包括考虑非药物治疗抑郁症,选择抗抑郁药具有较低的抗胆固醇作用,并管理其他跌倒风险因素.
- 多学科药物审查对于最大限度地减少抗胆固醇负担积累至关重要.
相关概念视频
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
847
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
847
Antidepressant Drugs: MAOIs and Other Agents
377
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
377
Parkinson's Disease: Treatment
389
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
389
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
617
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
617
Combined Effects of Drugs: Synergism
4.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.8K
Cholinergic Antagonists: Pharmacological Actions
1.3K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.3K


